317 related articles for article (PubMed ID: 16427098)
21. Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway.
Ishikawa A; Kadota T; Kadota K; Matsumura H; Nakamura S
Eur J Neurosci; 2005 Oct; 22(7):1713-9. PubMed ID: 16197511
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
Reid RT; Lloyd GK; Rao TS
Br J Pharmacol; 1999 Jul; 127(6):1486-94. PubMed ID: 10455300
[TBL] [Abstract][Full Text] [Related]
23. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
[TBL] [Abstract][Full Text] [Related]
24. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
25. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Jentsch JD; Wise A; Katz Z; Roth RH
Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior.
Goto Y; Grace AA
Nat Neurosci; 2005 Jun; 8(6):805-12. PubMed ID: 15908948
[TBL] [Abstract][Full Text] [Related]
27. Neural circuits engaged in ventral hippocampal modulation of dopamine function in medial prefrontal cortex and ventral striatum.
Taepavarapruk P; Howland JG; Ahn S; Phillips AG
Brain Struct Funct; 2008 Sep; 213(1-2):183-95. PubMed ID: 18288486
[TBL] [Abstract][Full Text] [Related]
28. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
29. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
Chung YC; Li Z; Dai J; Meltzer HY; Ichikawa J
Brain Res; 2004 Oct; 1023(1):54-63. PubMed ID: 15364019
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
Zornoza T; Cano-Cebrián MJ; Martínez-García F; Polache A; Granero L
Neuropharmacology; 2005 Dec; 49(7):1067-76. PubMed ID: 16040065
[TBL] [Abstract][Full Text] [Related]
31. Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain.
Corchero J; Oliva JM; García-Lecumberri C; Martin S; Ambrosio E; Manzanares J
J Psychopharmacol; 2004 Mar; 18(1):54-8. PubMed ID: 15107185
[TBL] [Abstract][Full Text] [Related]
32. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
[TBL] [Abstract][Full Text] [Related]
33. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic regulation of cortical acetylcholine release.
Day J; Fibiger HC
Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
[TBL] [Abstract][Full Text] [Related]
36. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
37. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
[TBL] [Abstract][Full Text] [Related]
38. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
Rodrigues LC; Conti CL; Nakamura-Palacios EM
Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
[TBL] [Abstract][Full Text] [Related]
39. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell.
Rada P; Avena NM; Hoebel BG
Neuroscience; 2005; 134(3):737-44. PubMed ID: 15987666
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
Zornoza T; Cano-Cebrián MJ; Miquel M; Aragón C; Polache A; Granero L
Neuropsychopharmacology; 2005 May; 30(5):843-52. PubMed ID: 15689964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
